Cheap Arthritis Drug Shows Promise Against RSV in Kids

A common, affordable arthritis medication could become the first antiviral treatment for RSV, the leading cause of infant hospitalizations in the U.

Early lab tests show the drug stops the virus from spreading in human respiratory cells without harming healthy tissue.